Mobile Contingency Management for Smoking Cessation
P3
2 other identifiers
interventional
532
1 country
1
Brief Summary
The purpose of the proposed project is to evaluate an automated mobile phone-based CM approach that will allow socioeconomically disadvantaged individuals to remotely benefit from financial incentives for smoking cessation. The investigators have previously combined technologies including 1) portable carbon monoxide monitors that connect with mobile phones to remotely verify smoking abstinence, 2) facial recognition software to confirm participant identity during breath sample submissions, and 3) remote delivery of incentives automatically triggered by biochemical confirmation of self-reported abstinence. This automated CM approach will be evaluated in a randomized controlled trial that includes 532 socioeconomically disadvantaged males and females seeking smoking cessation treatment. Participants will be randomly assigned to either telephone counseling and nicotine replacement therapy (standard care \[SC\]) or SC plus a mobile financial incentives intervention (CM) for biochemically-confirmed abstinence. Participants will be followed for 26 weeks after a scheduled quit attempt. Biochemically-verified 7-day point prevalence abstinence at 26 weeks post-quit will be the primary outcome variable. Cost-effectiveness will be evaluated to inform policy-related decisions. Potential mobile CM treatment mechanisms, including self-efficacy, motivation, and treatment engagement, will be explored to optimize future versions of the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 29, 2021
CompletedFirst Posted
Study publicly available on registry
May 11, 2021
CompletedStudy Start
First participant enrolled
November 8, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
ExpectedMarch 5, 2026
March 1, 2026
2.2 years
March 29, 2021
March 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Carbon monoxide-verified smoking abstinence
The primary outcome measure is carbon monoxide-verified 7-day point prevalence abstinence at 26 weeks post-quit.
26 weeks post-quit-date
Secondary Outcomes (5)
Cost-effectiveness
26 weeks post-quit-date
Carbon monoxide-verified smoking abstinence
12 week post-quit-date
Carbon monoxide-verified smoking abstinence
8 weeks post-quit-date
Carbon monoxide-verified smoking abstinence
4 weeks post-quit-date
Carbon monoxide-verified smoking abstinence
26 weeks post-quit-date
Study Arms (2)
Standard Care (SC)
ACTIVE COMPARATORParticipants randomized to Standard Care will be offered weekly smoking cessation counseling and pharmacotherapy.
Contingency Management (CM)
EXPERIMENTALCM participants will receive standard care in addition to small financial incentives for biochemically-verified abstinence.
Interventions
Financial incentives contingent upon smoking abstinence
Tobacco cessation telephone counseling and combination nicotine replacement therapy (nicotine patches + nicotine gum/lozenges)
Eligibility Criteria
You may qualify if:
- report an annual household income of \<200% of the federal poverty threshold (i.e., low-income)
- earn a score ≥4 on the REALM indicating \>6th grade English literacy level (i.e., a 7th grade reading level is necessary to complete assessments)
- are willing to quit smoking 7-14 days after enrollment
- are ≥ 18 years of age
- currently smoke ≥ 5 cigarettes per day
- have a CO level of \>6 ppm
- are willing to abstain from smoking cannabis and other combustible tobacco products (they raise CO levels and mask cigarette abstinence)
- have no contraindications for NRT
- Provide a copy/photo of driver's license or other documentation as proof of identity and U.S. residence
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Oklahomalead
- National Cancer Institute (NCI)collaborator
- M.D. Anderson Cancer Centercollaborator
- University of Floridacollaborator
- H. Lee Moffitt Cancer Center and Research Institutecollaborator
Study Sites (1)
TSET Health Promotion Research Center
Oklahoma City, Oklahoma, 73104, United States
Related Publications (1)
Kendzor DE, Businelle MS, Vidrine DJ, Frank-Pearce SG, Shih YT, Dallery J, Alexander AC, Boozary LK, Waring JJC, Ehlke SJ. Mobile contingency management for smoking cessation among socioeconomically disadvantaged adults: Protocol for a randomized trial. Contemp Clin Trials. 2022 Mar;114:106701. doi: 10.1016/j.cct.2022.106701. Epub 2022 Jan 31.
PMID: 35114409BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Darla E. Kendzor, PhD
University of Oklahoma
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 29, 2021
First Posted
May 11, 2021
Study Start
November 8, 2022
Primary Completion
January 31, 2025
Study Completion (Estimated)
September 1, 2026
Last Updated
March 5, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- De-identified data will be made available to investigators upon request after publication of the primary study findings.
- Access Criteria
- Data sharing agreement
De-identified data will be made available to investigators upon request, after publication of the primary study findings, and with a data-sharing agreement that specifies the investigator(s) will 1) use the data only for research purposes and not to identify any individual participant, 2) store the data on a secure device (e.g., encrypted, password-protected), and 3) destroy or return the data after completion of the analyses.